早产儿视网膜病变的最新研究进展

doi:10.3877/cma.j.issn.1673-5250.2012.06.030

中华妇幼临床医学杂志(电子版) ›› 2012, Vol. 08 ›› Issue (06) : 783 -786. doi: 10.3877/cma.j.issn.1673-5250.2012.06.030

所属专题：文献；

综述

早产儿视网膜病变的最新研究进展

张德双¹, 王华¹, 陈娟¹^,^*^,^*(

)

^1. 610041　成都，四川大学华西第二医院儿科

收稿日期:2012-06-22 修回日期:2012-10-09 出版日期:2012-12-01
通信作者: 陈娟

Latest Development of Retinopathy of Prematurity

De-shuang ZHANG¹, Hua WANG¹, Juan CHEN¹()

^1. Department of Pediatrics, West China Second University Hospital, Chengdu 610041, Sichuan Province, China

Received:2012-06-22 Revised:2012-10-09 Published:2012-12-01
Corresponding author: Juan CHEN
About author:
(Corresponding author: CHEN Juan, Email: chenjuan2000@163.com)

全文 ( ) 下载PDF ( ) 导出引用

早产儿视网膜病变(ROP)是指视网膜血管的异常增殖性疾病，是儿童致盲的主要原因。早产儿视网膜血管发育不完善是其根本原因。现就近年对ROP发病率、病因、发病机制、诊断及治疗等方面的最新研究进展进行综述，以提高对本病的认识，从而降低ROP发生率，改善儿童生存质量。

关键词: 视网膜病变, 早产儿

Retinopathy of prematurity(ROP) is a disease of abnormal proliferation of retinal vessel, which is a major cause of blindness in children. Developmental immaturity of retinal vessel is the basic reason in premature infants. We focus on incidence, etiology, pathogenesis, diagnosis, treatment and other new research of ROP, in order to improve knowledge of it, and reducing the incidence rate, improve the life quality of the children.

Key words: retinopathy, premature infant

[1]	Yan HL, Gao JL, ed. Pediatric ophthalmology[M].Beijing:People's Medical Publishing House, 2002, 76-82.
[2]	Shao XM, Ye HM, Qiu XC.Practical neonatology.4th ed[M].Beijing:People's Medical Publishing House, 2011, 887-892.
[3]	Adams GG.Editorial on retinopathy of prematurity[J].Early Hum Dev, 2008, 84(2):75-76.
[4]	Zhu L, Chen C, Shi WJ, et al.Multicenter screening and incidence investigation of retinopathy of prematurity[J].Chin J Perinat Med, 2006, 9(6):369-372.
[5]	Good WV. Early Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the early treatment for retinopathy of prematurity randomized trial[J]. Trans Am Ophthalmol Soc, 2004, 102:233-250.
[6]	Bizzarro MJ, Hussain N, Jonsson B, et al. Genetic susceptibility to retinopathy of prematurity[J]. Pediatrics, 2006, 118(5):1858-1863.
[7]	Sood BG, Madan A, Saha S, et al. Perinatal systemic inflammatory response syndrome and retinopathy of prematurity[J]. Pediatr Res, 2010, 67(4):394-400.
[8]	Huang XL, Zhang Y, Yang J, et al.Clinical analysis of the retinopathy of prematurity after criterion oxygen-treatment[J].Int J Ophthalmol, 2009, 9(4):693-694.
[9]	Sun LY, Zhao KX. The advance of molecular genetics in premature retinopathy[J].Chin J Ocul Fundus Dis, 2008, 24(1):68-70.
[10]	Mohamed S, Schaa K, Cooper ME, et al. Genetic contributions to the development of retinopathy of prematurity[J]. Pediatr Res, 2009, 65(2):193-197.
[11]	Yang H, Ding Y, Chen L.The study of the relationship between the trace elements and retinopathy of prematurity[J].Matern Child Health Care China, 2006, 21(19):2675-2678.
[12]	Wu WC, Ong FS, Kuo JZ, et al. Retinopathy of prematurity and maternal age[J]. Retina, 2010, 30(2):327-331.
[13]	Xiang JW, Huang XL, Huang SQ, et al. Influence of pulmonary surfactant on retinopathy in preterm infant[J].Guangdong Med J, 2009, 30(11):1640-1641.
[14]	Chen J, Stahl A, Hellstrom A, et al. Current update on retinopathy of prematurity: Screening and treatment[J]. Curr Opin Pediatr, 2011, 23(2):173-178.
[15]	Guo J, Xu GX, Chen JG.Study on related factors of retinopathy of prematurity and oxygen[J].Int J Ophthalmol, 2011, 11(11):2023-2024.
[16]	Finer N, Leone T. Oxygen saturation monitoring for the preterm infant: The evidence basis for current practice[J]. Pediatr Res, 2009, 65(4):375-380.
[17]	Clucas L, Doyle LW, Dawson J, et al. Compliance with alarm limits for pulse oximetry in very preterm infants[J]. Pediatrics, 2007, 119(6):1056-1060.
[18]	Salvin JH, Lehman SS, Jin J, et al. Update on retinopathy of prematurity:Treatment options and outcomes[J]. Curr Opin Ophthalmol, 2010, 21(5):329-334.
[19]	Gao L, Zhao XQ, Yip W, et al.Retinopathy of prematurity[J].Chin J Ocul Fundus Dis, 2005, 21(5):337-340.
[20]	Clark D, Mandal K. Treatment of retinopathy of prematurity[J]. Early Hum Dev, 2008, 84(2):94-99.

[1]	王珏, 陈赛君, 贲志飞, 詹锦勇, 徐开颖. 剪切波弹性成像联合极速脉搏波技术评估颈动脉弹性对糖尿病性视网膜病变的预测价值[J/OL]. 中华医学超声杂志（电子版）, 2023, 20(06): 636-641.
[2]	郭立珍, 范天群, 张欣凯, 蒋韵红, 金蓉, 刘冬云. 早产小于胎龄儿发生支气管肺发育不良的危险因素及预后分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(02): 209-215.
[3]	王叶青, 李利彤, 李伟绪, 曹猛. 牙周炎和糖尿病视网膜病变的因果关系：一项双向两样本孟德尔随机化分析[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(03): 160-168.
[4]	程莉, 章晓良. 血尿酸和胱抑素C与糖尿病视网膜病变患者合并糖尿病肾病的关系及影响因素[J/OL]. 中华肾病研究电子杂志, 2023, 12(04): 194-199.
[5]	罗桂彬, 沈强, 张蓝月, 刘涵. 晚期糖化终末产物与糖尿病视网膜病变相关性的研究进展[J/OL]. 中华眼科医学杂志(电子版), 2024, 14(04): 247-251.
[6]	王子琪, 李萍, 蔡标, 杨秀敏. 雌激素在糖尿病性视网膜病变中作用机制的研究进展[J/OL]. 中华眼科医学杂志(电子版), 2024, 14(03): 187-192.
[7]	董力, 李赫妍, 魏文斌. 人工智能在糖尿病视网膜病变中的应用进展[J/OL]. 中华眼科医学杂志(电子版), 2024, 14(01): 57-61.
[8]	刘涵, 沈强, 张蓝月, 陈健. 糖尿病视网膜病变分子生物标志物的研究进展[J/OL]. 中华眼科医学杂志(电子版), 2023, 13(06): 376-380.
[9]	李新星, 方晏红, 陈会振, 张蓝月, 刘涵. 维生素D与眼病关系的研究进展[J/OL]. 中华眼科医学杂志(电子版), 2023, 13(06): 366-370.
[10]	黄婵妍, 张妍春, 郑嘉敏, 王鑫晨. 循环及眼生物液标志物在早期糖尿病视网膜病变筛查和风险分层管理中的研究进展[J/OL]. 中华眼科医学杂志(电子版), 2023, 13(05): 306-310.
[11]	刘涵, 方晏红, 张蓝月, 李新星. 血脂异常与糖尿病视网膜病变的相关性研究进展[J/OL]. 中华眼科医学杂志(电子版), 2023, 13(05): 301-305.
[12]	李京珂, 张妍春, 武佳懿, 任秀瑜. 深度学习在糖尿病视网膜病变筛查、评级及管理中的研究进展[J/OL]. 中华眼科医学杂志(电子版), 2023, 13(04): 241-246.
[13]	张新媛, 王麒雲, 陈晓思. 糖尿病视网膜病变血管内皮细胞与神经细胞藕联二维体外共培养模型的实验研究[J/OL]. 中华眼科医学杂志(电子版), 2023, 13(01): 6-11.
[14]	邬秋俊, 向茜. 甘油三酯-葡萄糖指数与2型糖尿病微血管并发症相关性的研究进展[J/OL]. 中华临床医师杂志(电子版), 2023, 17(10): 1109-1112.
[15]	冉启玉, 汤怀鹏, 孔蕾, 孙冰. 糖尿病视网膜病变中神经退行性变的发病机制及其潜在的治疗方法[J/OL]. 中华诊断学电子杂志, 2023, 11(02): 120-124.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Latest Development of Retinopathy of Prematurity

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Latest Development of Retinopathy of Prematurity